Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus by A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study by Irena Ciećko-Michalska, Małgorzata Szczepanek, Beata Tobiasz-Adamczyk, Tomasz Mach

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review by Ewelina Jakielska, Paweł Głuszak, Marta Walczak, Wiesław Bryl

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study by I. Yu. Pirogova, S. V. Yakovleva, T. V. Neuymina, S. P. Sinitsyn, V. S. Chulkov, T. N. Shamaeva

Subjects: “…nonalcoholic fatty liver disease…”
Get full text

Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption by Mubin Ozercan, Ahmed Tawheed, Mohamed El-Kassas

Subjects: Get full text

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease by N. V. Bivalkevich, Yu. K. Denisenko, T. P. Novgorodtseva

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis by Tingting Kong, Yunpeng Gu, Lei Sun, Run Zhou, Jie Li, Junping Shi

Subjects: “…nonalcoholic fatty liver disease…”
Get full text

Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model by Sebastian Holländer, Maximilian von Heesen, Gereon Gäbelein, Julie Mercier, Matthias W. Laschke, Michael D. Menger, Matthias Glanemann, Antonios E. Spiliotis

Subjects: Get full text

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease by T. S. Krolevets, M. A. Livzan, S. I. Mozgovoy

Subjects: Get full text

The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates by Ruike Yan, Yanli Cao

Subjects: Get full text

Post-translational histone modifications associated with the development of metabolic dysfunction-associated fatty liver disease. Part 2. Histone methylation by O.E. Abaturov, A.O. Nikulina

Subjects: “…metabolic dysfunction-associated fatty liver disease…”
Get full text

Genome-wide association study of the fatty liver index in the Taiwanese population reveals shared and population-specific genetic risk factors across ethnicities by Pei Pei Lau, Chun-Yu Wei, Min-Rou Lin, Wan-Hsuan Chou, Yu-Jui Yvonne Wan, Wei-Chiao Chang

Subjects: “…Fatty liver disease…”
Get full text

Human umbilical cord derived-mesenchymal stem cells alleviate lipid metabolism disturbances of hepatocytes via mitochondrial transport by Jing Xue, Xiangnan Hu, Suying Xia, Pengfei Ren, Aihong Wang

Subjects: Get full text

Platelet‐derived apoptotic vesicles ameliorate nonalcoholic fatty liver disease by regulating lipid metabolism via apolipoprotein A‐II by Yuhe Jiang, Yike Liao, Zeying Wang, Lei Zhu, Yunsong Liu, Ping Zhang, Yuan Zhu, Wenyue Li, Yongsheng Zhou, Xiao Zhang

Subjects: Get full text

Exploring the molecular mechanisms of tirzepatide in alleviating metabolic dysfunction-associated fatty liver in mice through integration of metabolomics, lipidomics, and proteomic... by Jinliang Liang, Huanyi Liu, Guo Lv, Xiaotong Chen, Zhaoshou Yang, Kunhua Hu, Hongyan Sun

Subjects: “…Metabolic dysfunction-associated fatty liver disease…”
Get full text

Transcriptome analysis of liver injury of fatty liver disease induced by ALDH2 deficiency by Ziying Xu, Yagang Gao, Zihui Yu, Rui Zhang, Ruikun Wang, Shang Li, Shuowen Wang, Bing Du, Ziyan Tian, Lijuan Huang, Zanbo Ding, Jing Yuan

Subjects: Get full text

Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease—an observational study by Rongshan Fan, Yandong Li, Zeng Du

Subjects: “…metabolic-associated fatty liver disease…”
Get full text

Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review by Hongcai Li, Jingjing Liang, Mengzhen Han, Zhenpeng Gao

Subjects: “…Non-alcoholic fatty liver disease…”
Get full text

Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China by Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Yang W, Hong J, Zhang D, Li N

Subjects: “…metabolic-dysfunction-associated fatty liver disease…”
Get full text

Associations between Chinese Visceral Adiposity Index and the Risk of Metabolic Dysfunction-associated Steatotic Liver Disease and Liver Fibrosis: A Large Cross-sectional Study by Hui Liu, Mingming Deng, Gang Luo, Jie Chen

Subjects: Get full text